IMARA Inc.
PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE
Last updated:
Abstract:
The present disclosure relates to PDE9 inhibitors, pharmaceutical compositions comprising the PDE9 inhibitors, and methods of using the PDE9 pharmaceutical compositions for the treatment of sickle cell disease (SCD).
Status:
Application
Type:
Utility
Filling date:
4 Oct 2021
Issue date:
27 Jan 2022